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Apoptosis is a programmed cell death mechanism to
control cell number in tissues and to eliminate individ-
ual cells that may lead to disease states. The present
study investigates chromium(VI) (Cr(VI))-induced apo-
ptosis and the role of reactive oxygen species (ROS) and
p53 in this response. Treatment of human lung epithe-
lial cells (A549) with Cr(VI) caused apoptosis as meas-
ured by DNA fragmentation, mitochondria damage, and
cell morphology. Cr(VI)-induced apoptosis is contrib-
uted to ROS generation, resulting from cellular reduc-
tion of Cr(VI) as measured by flow cytometric analysis of
the stained cells, oxygen consumption, and electron spin
resonance spin trapping. Scavengers of ROS, such as
catalase, aspirin, and N-acetyl-L-cysteine, decreased
Cr(VI)-induced apoptosis, whereas NADPH and gluta-
thione reductase, enhancers of Cr(VI)-induced ROS gen-
eration, increased it. p53 is activated by Cr(VI), mostly
by ROS-mediated free radical reactions. Cr(VI)-induced
ROS generation occurred within a few minutes after
Cr(VI) treatment of the cells, whereas p53 induction
took at least 5 h. The level of Cr(VI)-induced apoptosis
was similar in both p53-positive cells and p53-negative
cells independent of p53 status in the early stage (0–3 h)
of Cr(VI) treatment. However, at the later stage (3–24 h),
the level of the apoptosis is higher in p53-positive cells
than in p53-negative cells. These results suggest that
ROS generated through Cr(VI) reduction is responsible
to the early stage of apoptosis, whereas p53 contributes
to the late stage of apoptosis and is responsible for the
enhancement of Cr(VI)-induced apoptosis at this stage.
Apoptosis is a process in which cell death is initiated and
completed in an orderly manner through activation and/or syn-
thesis of gene products necessary for cell destruction (1). It is a
response to physiologic and pathologic stresses that disrupt the
balance between the rates of cell division and elimination. In
diseases such as cancer, there is an imbalance between the rate
of cell proliferation and cell death. Agents that promote or
suppress apoptosis can alter the rates of cell division and
death, influencing the anomalous accumulation of neoplastic
cells.
Although many questions remain to be answered, it is gen-
erally believed that in certain cell types, oxidative stress is a
critical part of the apoptotic process (2). It has been reported
that oxidant or oxidant-promoting agents cause necrosis at
higher concentrations and apoptosis at lower concentrations
(2). Antioxidants can inhibit or delay oxidative stress-induced
apoptosis (2). Another important mediator of apoptosis is p53
(3, 4). Activation of p53 involves growth arrest and/or apopto-
sis. Recent studies indicate that reactive oxygen species (ROS)1
are downstream mediators of p53-dependent apoptosis (4, 5).
p53 results in apoptosis through a multi-step process (4): (a)
the transcriptional induction of redox-related genes; (b) the
generation of ROS; and (c) the oxidative degradation of mito-
chondrial components, leading to apoptosis.
The present study focuses on Cr(VI)-induced apoptosis.
Cr(VI) compounds are highly toxic and carcinogenic (6). They
are potent inducers of tumors in experimental animals. They
cause DNA damage, such as DNA strand breaks and dG hy-
droxylation (6). Earlier studies have shown that in cellular
systems, Cr(VI) is reduced by certain flavoenzymes such as
glutathione reductase to generate Cr(V) (7–9). During this
process, molecular oxygen is reduced to O2
., which generates
H2O2 via dismutation (7). The resultant Cr(V) reacts with H2O2
to generate zOH radical via a Fenton-like reaction. Thus, dur-
ing the one-electron reduction of Cr(VI), a whole spectrum of
ROS are generated. Through ROS-mediated reactions, Cr(VI)
is able to cause DNA damage (10) and activation of nuclear
transcription factor NF-kB (11).
It is generally believed that ROS play an important role in
carcinogenesis induced by a variety of carcinogens. The net
effect of the response is determined by a balance between
intercellular oxidants and antioxidants. ROS-mediated reac-
tions are believed to play a key role in Cr(VI)-induced DNA
damage. Cell cycle surveillance mechanisms set checkpoints for
cell cycle progression. If the cell is damaged by external agent,
such as Cr(VI), that may cause DNA breaks, cell cycle progres-
sion will be transiently delayed to allow the cell to repair the
damaged DNA. If the DNA is severely damaged, the cell will
undergo apoptosis (12). Apoptosis is a defense mechanism by
which the body can eliminate damaged cells. Thus investiga-
tion on the role of ROS in Cr(VI) induced apoptosis is important
to understand the mechanism of carcinogenesis caused by not
only Cr(VI) but also by other carcinogens. We report here that
Cr(VI) is a direct ROS promoting agent that causes mitochon-
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dria damage and induces apoptosis. The apoptotic processes
involves both p53-independent and p53-dependent pathways.
MATERIALS AND METHODS
Reagents—Potassium dichromate (Cr(VI)) and chromium fluoride
(Cr(III)) were purchased from Aldrich. Chromium-GSH complex
(Cr(IV)) was synthesized according to the method described earlier (13).
Aspirin, b-nicotinamide adenine dinucleotide phosphate (NADPH), N-
acetyl-L-cysteine (NAC), DCFH-DA, and cyclosporine A (CsA) were
purchased from Sigma. Superoxide dismutase (SOD) and catalase were
purchased from Roche Molecular Biochemicals. Dihydroethidium, JC-1,
and DiOC6 were purchased from Molecular Probe (Eugene, OR).
Cell Culture—The human lung epithelial cell lines (A549 and H1299)
and the human prostate epithelial cell line PC3 were purchased from
the American Type Culture Collection (Manassas, VA). The cells were
cultured at 37 °C in a 5% CO2 incubator with RPMI 1640 cell culture
medium that was supplemented with 5% fetal calf serum, 2 mM L-
glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin. The
cells form a monolayer at confluence. Trypsin (0.25%) EDTA solution
was used to detach the cells from the culture flask for plating and
passing the cells.
Apotosis Assay—The cells were plated in a 96-well plate at a density
of 2 3 104 cells/well in supplemented RPMI 1640 and incubated for16 h
before the cells were subjected to treatment in triplicate wells. After
treatment, the cells were washed twice in phosphate-buffered saline
(PBS) (2.68 mM KCl, 1.47 M KH2PO4, 8 mM Na2KPO4, 136.75 mM NaCl),
and apoptosis was quantitated by measuring the levels of cytosolic
histone-bound DNA fragments. This was done by using a cell death
enzyme-linked immunosorbent assay kit manufactured by Roche Mo-
lecular Biochemicals. The assays were carried out according to the
protocol provided by the manufacturer. Briefly, the cells were lysed
with 200 ml of lysis buffer at room temperature. The lysate from three
identical wells was combined, and 20 ml of the resulted lysate was
mixed with 80 ml of antibody solution in a well of the enzyme-linked
immunosorbent assay plate. The loaded wells were incubated at room
temperature for 2 h. The substrate was added after the wells were
washed three times in washing buffer. After incubation at 37 °C for
10–20 min, the reaction was stopped, and optical density was measured
using a microplate reader at a wavelength of 405 nm. The readings were
used to represent the degree of apoptosis. A mean value of three sepa-
rate experiments was for analysis.
Morphological Analysis—Apoptosis was also examined by morpho-
logical analysis. At the end of chromium treatment, the cells were
washed twice in PBS and then fixed with 10% buffered formalin. The
cells were stained with Wright staining kit containing solutions A, B,
and C (Volu-Sol, Inc., Louisville, KY). The staining was conducted in a
96-well tissue culture plate according to the manufacturer’s protocol.
The cells were stained in 100 ml of Wright’s stain solution (solution A)
for 2 min, treated with 100 ml solution B for 1.5 min, and then rinsed in
solution C for 10 s. After being air-dried, the stained cells were observed
under a Leitz inverted microscope. The cell image was captured with a
Sony 3CCD color video camera and printed with a Sony color video
printer.
Fluorescence-activated Cytometry Sorter Analysis—The sample cells
were suspended in 1 ml of PBS containing 0.1 mg/ml propidium iodine
5 min before flow cytometry assay. JC-1 was excited at 490 nm and
detected at 600 nm. DiOC6 was excited at 488 nm and detected at 525
nm. Dihydroethidium was excited at 490 nm and detected at 620 nm.
DCFH-DA was excited at 488 nm and detected at 525 nm.
Mitochondrial trans-Membrane Potential (Dcm) Assay—JC-1 (14, 15)
and DiOC6 (16–18) are two mitochondria specific flourescent dye. They
have been widely used in monitoring Dcm. The dye was dissolved in
Me2SO and diluted with PBS at 1:1000. The cells were plated in a 6-well
plate at 5 3 105/well 16 h before treatment. After the cells were treated
with chromium, the diluted dyes were applied to the cells for 15 min at
37 °C. The final concentrations were 10 mg/ml for JC-1 and 40 nM for
DiOC6. Then the cells were washed twice in PBS and harvested for
FACS analysis.
Cellular Superoxide (O2
.) and H2O2 Assay—Dihydroethidium is a
O2
.-specific dye (19, 20). Dihydroethidium was dissolved in Me2SO at
2 mM and kept at 220 °C. The cells were plated in a 6-well plate at
5 3 105/well 16 h before treatment. Dihydroethidium was added into
the cell culture 15 min before the treatment was completed, and the
staining was carried out at 37 °C. The final Me2SO concentration in
the cells culture was 0.1%. Then the cells were washed in PBS and
harvested for FACS analysis. In the case of cellular image, the cells
(2 3 104/well) were plated onto a glass slip in the 24-well plate. After
being stained, the cells were washed in PBS and fixed with 10%
buffered formalin. The slip was mounted on a glass slide and observed
using a Saratro 2000 (Molecular Dynamics, Inc., Sunnyrale, CA) laser
scanning confocal microscope (Optiphot-2, Nikon, Inc., Melville, PA)
fitted with an argon-ion laser. DCFH-DA has been used frequently to
monitor oxidative burst (5) and H2O2 level inside the cells (17, 21).
Under the same condition, DCFH-DA (5 mM) was used to stain H2O2
inside the cells.
p53 Protein Assay—p53 protein was analyzed by Western blot assay.
The cells were plated in a 100-mm culture dish and treated with
chromium. The nuclear protein was prepared as described before (22).
Briefly, 5 3 107 cells were treated with 500 ml of lysis buffer (50 mM
KCl, 0.5% Nonidet P-40, 25 mM HEPES, pH 7.8, 1 mM phenylmethyl-
sulfonyl fluoride, 10 mg/ml leupeptin, 20 mg/ml aprotinin, 100 mM dithi-
othreitol) on ice for 4 min. After 1 min of centrifugation at 14,000 rpm,
the supernatant was saved as a cytoplasmic extract. The nuclei were
washed once with the same volume of buffer without Nonidet P-40 and
then were treated with 300 ml of extraction buffer (500 mM KCl, 10%
glycerol with the same concentrations of HEPES, phenylmethylsulfonyl
fluoride, leupeptin, aprotinin, and dithiothreitol as the lysis buffer) and
pipetted several times. After centrifugation at 14,000 rpm for 5 min, the
supernatant was harvested as the nuclear protein extract and stored at
270 °C. The protein concentration was determined using BCA protein
assay reagent (Pierce). A standard Western blot was carried out to
detect p53 protein level in 10 mg of the nuclear protein. Monoclonal p53
antibody (sc-126) was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA).
Oxygen Consumption Measurements—Oxygen consumption meas-
urements were carried out using Gilson oxygraph equipped with a
Clark electrode (Gilson Medical Electronics, Middledton, WI). Measure-
ments were made from mixtures containing 1.0 3 106/ml cells, 300 mM
Cr(VI), 300 mM Cr(IV), 300 mM Cr(III), and 1 mM NADPH in a total
volume of 1.5 ml. The oxygraph was calibrated with medium equili-
brated with oxygen of known concentrations.
ESR Measurements—ESR spin trapping technique was used to de-
tect short-lived free radical intermediates. This technique involves the
addition-type reaction of a short-lived radical with a paramagnetic
compound (spin trap) to form a relatively long-lived free radical product
(spin adduct), which can then be studied using conventional ESR. The
intensity of the signal is used to measure the amount of short-lived
radicals trapped, and the hyperfine couplings of the spin adduct are
generally characteristics of the original trapped radicals. The spin
trapping is a method of choice for detection and identification of free
radical generation because of its specificity and sensitivity. All ESR
measurement were conducted using a Varian E9 ESR spectrometer and
a flat cell assembly. Reactants were mixed in a test tube in a final
volume of 500 ml. The reaction mixture was then transferred to a flat
cell for ESR measurement. Hyperfine couplings were measured (to 0.1
G) and 1,1-diphenyl-2-picrylhydrazyl was used as a reference. The
relative radical concentration was estimated by multiplying half of the
peak height by (DHpp)
2, where DHpp represents peak-to-peak width. The
program EPRDAP, version 2.0, was used for data acquisition and
analysis.
RESULTS
Induction of Apoptosis by Cr(VI)—The human lung tumor
cell line, A549, was used to study Cr(VI)-induced apoptosis.
DNA fragmentation assay was carried out by detection of his-
tone-bound DNA fragments in a whole cell lysate with a cell
death enzyme-linked immunosorbent assay system as stated
under “Materials and Methods.” Indeed, Cr(VI) was able to
induce apoptosis in A549 cells. The induction of apoptosis is
dose-dependent (Fig. 1A). The apoptosis increased with Cr(VI)
concentrations from 75 to 300 mM, saturated at a dose above
300 mM, and decreased slightly at 500 mM. Thus, 300 mM was
used for all experiments in this study. At this concentration,
Cr(VI)-induced apoptosis depended upon incubation time (Fig.
1B). The earliest time for DNA fragmentation to be detectable
was 2 h after the Cr(VI) treatment. The DNA fragmentation
increased thereafter until 24 h and then decreased (Fig. 1B)
Observation of the cell morphology also indicates that Cr(VI) is
able to induce apoptosis in the lung type II epithelial cells (Fig. 2).
The Cr(VI)-treated cells undergo condensation of both the cyto-
plasm and the nucleus, which is typical of the apoptotic process.
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Mitochondria are the limiting factor in the apoptosis path-
way in many experimental systems (23). Disruption of mito-
chondria transmembrane potential (Dcm) has been an estab-
lished indicator of mitochondrial damage in the progression of
apoptosis (14, 19). Two mitochondria-specific dyes, JC-1 (13,
14) and DiOC6 (16–18), were employed for this purpose, and
FACS analysis was conducted. The result shows that at 16 h
post-treatment with 300 mM Cr(VI), Dcm was significantly re-
duced (Fig. 3). The gated population of stained cells dropped
from 98 to 63% for JC-1 staining and from 82 to 67% for DiOC6
staining, confirming damage at the mitochondrial level, which
may be related to the apoptotic response of the cells to Cr(VI).
Role of p53 in the Metal-induced Apoptosis—The tumor sup-
pressor gene product, p53, has been reported to mediate apop-
tosis in many experimental systems. It is believed that this
activity is responsible for the tumor suppressive function of p53
(24–26). This section examines whether p53 protein is involved
in Cr(VI)-induced apoptosis. The p53 activity was studied by
extracting nuclear protein from Cr(VI)-treated cells and mon-
itoring the p53 protein by immunoblot analysis (Fig. 4). The
p53 protein was detectable in the nuclear extract of the un-
treated cells (Fig. 4, lane 1). After an exposure to Cr(VI), the
p53 protein level was elevated in a time-dependent manner. A
Cr(VI)-induced increase in p53 was not noticeable at 0.5, 1, 2,
or 3 h during the period of Cr(VI) treatment (Fig. 4, lanes 2–5).
However, an increase in the p53 level was observed at 2 h after
a 3-h incubation of the cells with Cr(VI) (Fig. 4, lane 6), and this
increase reached its peak at 20 h after the treatment (Fig. 4,
lane 8). Housekeeping transcription factor YY1 was used as a
protein loading control.
The above results demonstrate that p53 was activated by
Cr(VI) because nuclear p53 level was induced. The question to
be answered is whether p53 activation contributed to the pro-
gression of Cr(VI)-induced apoptosis. p53-positive and -nega-
tive cell lines were employed to address this question. A549 is
a p53-positive cell line. Both H1299, a human lung tumor cell
line (25), and PC3, a human prostate tumor cell line (27), are
p53-negative cells. These three cells types were treated for 3 h
with Cr(VI) at different concentrations and examined for ap-
optosis 24 h later. The results show that, at all three concen-
trations, the p53-positive cells expressed much stronger apo-
ptosis than the p53-negative cells (Fig. 5A). In the time course
analysis, both A549 (p531) and H1299 (p532) cells were
treated with 300 mM Cr(VI), and apoptosis was monitored at
different times post-treatment (Fig. 5B). The results show that,
at the early stage (,3 h), there was no difference between the
p53-positive and -negative cells, indicating that p53 does not
play a significant role at this stage of Cr(VI)-induced apoptosis.
A difference in the rate of apoptosis was observed at 12 h
post-treatment, and at 24 h, apoptosis in A549 cells was twice
that found in H1299 cells. This difference in Cr(VI)-induced
apoptosis exhibited in the p53 wild type and mutant type cells
suggests that both p53-independent and p53-dependent path-
ways may be involved in at the later stage of Cr(VI)-induced
apoptosis.
Detection of ROS Formation—ROS are considered to play a
major role in Cr(VI)-induced carcinogenesis. For example,
through ROS, Cr(VI) causes DNA damage (10, 28) and NF-kB
activation (11, 29). We therefore examined ROS generation in
the Cr(VI)-treated cells. The ability of Cr(VI) to generate zOH
radicals was examined using an ESR spin trapping method.
Fig. 6A shows a typical ESR spectrum generated by cellular
reduction of Cr(VI) from a reaction mixture containing Cr(VI)
and A549 cells in pH 7.4 phosphate-buffered solution. The
spectrum consists of an 1:2:2:1 quartet with splittings of aH 5
aN 5 14.9 G, where aN and aH denote hyperfine splittings of the
nitroxyl nitrogen and a-hydrogen, respectively. Based on these
splittings and the 1:2:2:1 line shape (9), this spectrum was
assigned to the DMPO/2OH adduct, which is evidence of 2OH
radical generation. In the presence of NADPH, the signal was
enhanced (Fig. 6B). The peak at g 5 1.9792 was assigned to
Cr(V) according to the value reported in the literature for the
Cr(V) species (9). Addition of catalase completely eliminated
the signals of DMPO/zOH (Fig. 6C), indicating that zOH radical
generation involves H2O2 via a Fenton-like reaction.
The ability of Cr(VI) to generate O2
., and H2O2 in the human
epthelial cells was analyzed by intracellular staining of O2
. and
H2O2. Hydroethidine, a specific fluorescent dye for O2
., and
DCFH-DA, a fluorescent dye for H2O2, were applied to cells for
tracking generation of ROS. The cells were examined with a
laser scanning confocal microscope. Both O2
. and H2O2 were
visualized inside the untreated cells (Fig. 7A, Untreated). Be-
cause these oxygen species are mainly produced in the mito-
chondria, the bright color fluorescent dots in the cytoplasm
represent subcellular location of O2
. and H2O2, respectively. In
FIG. 1. Cr(VI)-induced apoptosis. A, A549 cells were seeded in a
96-well plate at a density of 1 3 104/well. Cr(VI) was added to the cell
culture at the final concentrations indicated. After an exposure of 3 h,
Cr(VI) was removed, and the culture was supplemented with the fresh
cell medium. Histone protein assay was carried out 24 h later. B, the
cells were treated with Cr(VI) at a final concentration of 300 mM for 3 h
and then cultured in fresh cell medium. The histone protein assay was
conducted at different times as shown after Cr(VI) treatment. The mean
value 6 S.D. were from the results of three independent experiments. *
indicates a significant increase from control (p , 0.05). 2 indicates a
significant decrease from the 24 h values (p , 0.05).
FIG. 2. At 24 h after Cr(VI) treat-
ment, the cell morphology was exam-
ined under a microscope at a magnifi-
cation of 10 3 40, and the image was
captured with an attached camcorder.
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the presence of Cr(VI), both O2
. and H2O2 were dramatically
enhanced (Fig. 7A, Cr(VI) Treated). This increase occurred
within 30 min. Hydroethidine exhibits a red or orange color
after being oxidized by O2
.. DCFH-DA exhibits green and or-
ange colors after being oxidized.
The generation of O2
. and H2O2 was quantified by flow cy-
tometry analysis of the stained cells. For O2
., the gated cell
population increased from 36 to 62% after Cr(VI) treatment
(Fig. 7B). In the presence of SOD, the Cr(VI)-induced popula-
tion dropped from 62 to 46%. SOD treatment reduced the basal
population from 36 to 30%. These results confirm at the cellular
level that Cr(VI) induced ROS production after penetrating
into the cells. In addition, SOD is able to pass the cell mem-
brane and prevent accumulation of O2
. resulting from reduction
of Cr(VI). A similar result was obtained for H2O2 by flow
cytometry (data not shown). Because O2
. is the one-electron
reduction product of molecular oxygen, the O2 consumption
from cells treated with Cr(VI) was measured using an oxy-
graph. As shown in Fig. 7C, Cr(VI) enhanced the O2 consump-
tion, and NADPH was able to accelerate it slightly. Cr(III) or
Cr(IV) did not exhibit any observable activity.
Role of ROS in Cr(VI)-induced Apoptosis—Several strategies
were used to investigate the role of the radicals in Cr(VI)-
induced apoptosis. Different oxidative states of chromium were
examined for their activity in induction of apoptosis. Cr(III),
Cr(IV), and Cr(VI) exhibit different activities in the generation
of free radicals, with Cr(VI) being the strongest one. Results of
the apoptosis assay indicate that although Cr(III) and Cr(IV)
were able to induce apoptosis slightly, their activities were
much weaker than that of Cr(VI) (Fig. 8A). This is in line with
the fact that Cr(VI) can be rapidly reduced to the lower oxida-
tive state such as Cr(V) and ROS are generated during the
reaction. In the presence of NADPH, the free radical production
was enhanced (Fig. 6B). As reported earlier, glutathione reduc-
tase is another major Cr(VI) reductant. Both of these reagents
promoted Cr(VI)-induced apoptosis (Fig. 8B). The effects of
antioxidants were also examined in this experimental system.
Catalase, (5), aspirin (30), and NAC (5) are established anti-
oxidants. Their ability to block Cr(VI)-induced apoptosis were
examined. The cells were pretreated with each of the three
antioxidants and then analyzed for Cr(VI)-induced apoptosis.
The results shows that all of three antioxidants were effective
in inhibiting Cr(VI)-induced apoptosis (Fig. 8C). The reduction
was 40% by catalase, 50% by aspirin, and 90% by NAC, dem-
onstrating a role of ROS in the Cr(VI)-induced apoptosis.
The previous sections have shown that Cr(VI) is able to
activate p53 and that p53 induction is involved in Cr(VI)-
induced apoptosis. p53 is a transcription factor involved in the
FIG. 3. Mitochondrial damage and morphological assay. The
cells were treated with 300 mM Cr(VI) for 3 h, and mitochondrial
trans-membrane potential was examined 16 h later by FACS with JC-1
or DiOC6 staining.
FIG. 4. Cr(VI)-induced p53 activation. p53 protein level was ex-
amined in 10 mg of the nuclear extract of A549 cells by Western blot
after 300 mM Cr(VI) treatment. Monoclonal p53 antibody (sc-126, Santa
Cruz Biotechnology) was used in the assay. Lane 1, untreated cells;
lanes 2–5, p53 protein level examined immediately after 1, 2, or 3 h of
300 mM Cr(VI) treatment; lanes 6–8, p53 protein level examined 2, 8, or
24 h after 3 h of Cr(VI) treatment. YY1 serves as a protein loading
control.
FIG. 5. Role of p53 in Cr(VI)-induced apoptosis. A, p53-positive
(A549) and -negative (H1299, PC3) cell lines were treated with Cr(VI) at
different concentrations as indicated. The histone protein assay was
conducted of 24 h. * and 1 indicate a significant difference from A549
cells (p , 0.05). B, A549 and H1299 cells were treated with 300 mM
Cr(VI), and histone protein assay was conduced at different times as
indicated. * indicates a significant increase from H1299 cells (p , 0.05).
FIG. 6. Measurement of Cr(VI)-induced ROS generation. A,
ESR spectrum was recorded 2 min after reaction initiation from a
mixture containing1 3 106 A549 cells/ml, 1 mM Cr(VI) and 100 mM
DMPO. B, same as A but with 1 mM NADPH added. C, same as A but
with 5,000 units/ml catalase added.
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activation of man oxidative stress genes (4). It has been re-
ported that p53 gene product causes apoptosis using ROS as
downstream mediators. Because there are two mechanisms of
ROS generation, the direct generation of ROS from Cr(VI)
reaction and the p53-mediated transcriptional activation, this
section examines which mechanism is critical for the initiation
of apoptosis, focusing on the early events of apoptosis before
p53 activation. Mitochondrial damage was observed in the
early stage of Cr(VI) treatment. The damage was detected with
FACS analysis of the JC-1-stained cells. In the presence of
Cr(VI), the gated cell population was dropped from 36 to 25%
within 2.5 h (Fig. 9A). CsA is an inhibitor of mitochondrial
permeability transition (17). Inhibition of permeability transi-
tion leads to prevention of Dcm disruption. CsA was utilized to
prevent the metal-induced mitochondrial damage. The result
showed that CsA pretreatment can prevent Cr(VI)-induced
Dcm disruption (Fig. 9A). CaA pretreatment also reduced
Cr(VI)-induced DNA fragment (Fig. 9B), suggesting mitochon-
drial involvement in the initiation of Cr(VI)-induced apoptosis,
which seems p53-independent.
DISCUSSION
The present study shows that Cr(VI) is able to cause apop-
tosis in the epithelial cell line A549. ROS are involved in the
apoptotic response. The following experimental observations
support this conclusion: (a) Reaction of Cr(VI) with cells gen-
FIG. 7. O2
. and H2O2 generation in-
side the cells and O2 consumption. A,
for staining of O2
. and H2O2, A549 cells
were treated with 300 mM Cr(VI) in the
presence of 2 mM dihydroethidium or 5 mM
DCFH-DA for 30 min. For O2
. and H2O2
image, the cells were washed once in PBS
and fixed with 10% buffered formalin.
The bright color dots in the cells represent
O2
. and H2O2. The images were captured
with a confocal microscope. B, quantita-
tion of O2
. by FACS. SOD was used to
pretreat the cells and inhibit accumula-
tion of O2
. inside the cells. C, oxygen con-
sumption by A549 cells treated with var-
ious agents as indicated. * indicates a
significant increase from control (p ,
0.05). 2 indicates no significant differ-
ence from control.
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erates ROS; (b) NADPH and glutathione reductase enhances
the ROS generation and Cr(VI)-induced apoptosis; (c) Cr(VI)-
induced apotosis can be inhibited by antioxidants including
catalase, aspirin, and NAC; and (d) The apoptotic potential of
chromium with different oxidative states is associated with the
ability to generate ROS. Among these species, Cr(VI) is most
potent in ROS generation and apoptosis induction.
It has been reported that ROS are downstream mediators in
the p53-dependent apoptotic pathway (4, 5). The present study
demonstrates that Cr(VI) is able to induce activation of p53
protein. p53 protein is a tumor suppressor protein that trans-
mits signals arising from various forms of cellular stress, in-
cluding DNA damage and hypoxia, to genes and factors that
induce cell cycle arrest and apoptosis (31). The p53 signaling
pathway can be divided into two parts, upstream of p53 and
downstream of p53. The immediate downstream components of
the p53 pathway are p53 transactivation targets. The present
study shows that an accumulation of p53 protein was induced
by Cr(VI) and that p53 is involved in the Cr(VI)-induced apo-
ptosis. It has been reported that a dozen genes can be induced
by more than 10-fold when p53 level was increased in the cells.
It may be noted that more than half of those genes are directly
or indirectly involved in metabolism of ROS, and ROS are
required in the p53-dependent apoptotic pathway (4). Because
the results obtained from the present study show that antioxi-
dants and enhancers of ROS generation modulate Cr(VI)-in-
duced apoptosis, it appears that ROS generated by p53 activa-
tion may also contribute to Cr(VI)-induced apoptosis.
In addition to the p53-dependent pathway, this study also
demonstrates that Cr(VI) is able to induce apoptosis through
p53-independent pathway. As discussed above, ROS can be
generated by two different mechanisms. One is the direct ROS
generation in the Cr(VI) reduction process. The other is p53-
mediated ROS production. The following observations support
the hypothesis that Cr(VI) can induce apoptosis through a
p53-independent pathway: (a) Cr(VI)-induced mitochondrial
damage occurred within 3 h. In this period p53 has not been
activated. Blockage of ROS by antioxidants prevented the mi-
tochondrial damage and apoptosis. (b) Cr(VI)-induced DNA
fragmentation became detectable at the same time when p53
was activated. If the DNA fragmentation was dependent on p53
activation, it should happen after p53 activation. (c) Cr(VI) is
able to induce apoptosis in the p53-negative cells. At the early
stage of apoptotic response, the p53-negative cells and p53-
positive cells expressed similar levels of Cr(VI)-induced apo-
ptosis. At the late stage, the p53 wild type cells exhibited a
higher level of apoptosis. This indicates that at this stage,
Cr(VI) induces apoptosis through both p53-dependent and p53-
independent pathways. (d) ROS generated by cellular reduc-
tion of Cr(VI) occurs within 30 min. In contrast, p53-mediated
ROS production can only occur after p53 is activated. This
activation process takes a much longer time.
The results obtained from the present study support the
following conclusions: (a) In the apoptotic signaling pathway,
ROS generated from both Cr(VI) reduction and p53 activation
play important roles. (b) The Cr(VI)-derived ROS initiate ap-
optosis before activation of p53 protein. (c) Although p53 is not
required for initiation of Cr(VI)-induced apoptosis, it may en-
hance apoptosis by transcriptional activation of redox-related
FIG. 8. Role of ROS in Cr(VI)-induced apoptosis. A, the cells
were treated with Cr(VI), Cr(IV), or Cr(III) at a final concentration of
300 mM for 3 h. The histone protein assay was conduced 24 h later. B,
the cells were treated with 300 mM Cr(VI) in the presence NADPH or
glutathione reductase for 3 h. The histone protein assay were carried
out 24 h later. C, the cells were pretreated with 5,000 units/ml catalase,
2.5 mM aspirin, or 20 mM NAC for 0.5 h, and then Cr(VI) was added.
After 3 h of treatment, the cells were subjected to histone protein assay
in 24 h. The mean values 6 S.D. were from three independent experi-
ments. * indicates a significant increase from control (p , 0.05). 2
indicates a significant decrease from Cr(VI)-treated cells.
FIG. 9. Effect of CsA on Cr(VI)-induced apoptosis. A, mitochon-
drial trans-membrane potential was monitored with JC-1 immediately
after 300 mM Cr(VI) treatment for 2 h. The cells were pretreated with 1
mM CsA before Cr(VI) was added. B, histone protein assay after CsA
treatment. The histone protein assay was carried out at 2 h after a 3-h
treatment of the A549 cells with 300 mM Cr(VI). The mean values 6 S.D.
were from three independent experiments. * indicates a significant
increase from control (p , 0.05). 2 indicates a significant decrease from
Cr(VI)-treated cells (p , 0.05).
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genes. (d) Cr(VI) induces apoptosis through both p53-depend-
ent and p53-independent pathways. (e) ROS generated by
Cr(VI) may play a dual role in the mechanism of Cr(VI)-in-
duced carcinogenesis: genetic damage and apoptosis. The
Cr(VI)-induced carcinogenesis may depend on the balance of
these two opposite processes. (f) it may be speculated that other
metal carcinogenes, such as vanadium, cobalt, and nickal,
which are also direct ROS-promoting agents (32, 33), may
cause apoptosis by a mechanism similar to that of Cr(VI).
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